Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Bionime Corporation (4737) Financial Statements

Bionime Corporation Financial Overview

Bionime Corporation's market cap is currently NT$4.18B. The company's EPS TTM is NT$-4.03; its P/E ratio is -13.50; and it has a dividend yield of 3.02%. Bionime Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.84BNT$ 1.93BNT$ 1.76BNT$ 2.21BNT$ 1.85B
Gross ProfitNT$ 627.81MNT$ 768.38MNT$ 715.65MNT$ 1.00BNT$ 783.13M
Operating IncomeNT$ -197.36MNT$ -129.05MNT$ -13.34MNT$ 146.72MNT$ 73.07M
EBITDANT$ -15.08MNT$ 59.28MNT$ 179.78MNT$ 270.36MNT$ 248.29M
Net IncomeNT$ -180.28MNT$ -127.22MNT$ 6.21MNT$ 91.03MNT$ 87.41M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 485.01MNT$ 382.59MNT$ 449.21MNT$ 277.88MNT$ 312.91M
Total AssetsNT$ 5.70BNT$ 5.78BNT$ 5.30BNT$ 4.98BNT$ 4.56B
Total DebtNT$ 3.06BNT$ 3.17BNT$ 2.82BNT$ 2.27BNT$ 2.03B
Net DebtNT$ 2.64BNT$ 2.85BNT$ 2.43BNT$ 2.06BNT$ 1.78B
Total LiabilitiesNT$ 3.95BNT$ 3.89BNT$ 3.31BNT$ 2.90BNT$ 2.49B
Stockholders' EquityNT$ 1.75BNT$ 1.88BNT$ 1.99BNT$ 2.07BNT$ 2.07B
Cash Flow
Free Cash FlowNT$ 206.41MNT$ -313.29MNT$ -237.95MNT$ -170.63MNT$ -14.85M
Operating Cash FlowNT$ 494.80MNT$ 19.53MNT$ 203.44MNT$ 142.29MNT$ 269.72M
Investing Cash FlowNT$ -286.07MNT$ -336.90MNT$ -435.26MNT$ -312.26MNT$ -288.07M
Financing Cash FlowNT$ -108.53MNT$ 217.30MNT$ 420.40MNT$ 113.64MNT$ -69.30M

Currency in TWD

Bionime Corporation Earnings and Revenue History

-1.2B01.2B2.4B-20 %-10 %0 %10 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Bionime Corporation Liabilities to Assets

02.5B5B7.5B48 %56 %64 %72 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Bionime Corporation Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Bionime Corporation Forecast EPS vs Actual EPS

-1.6-1.4-1.2-1-0.8-0.6Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >